ATAI logo

Atai Life Sciences NV (ATAI)

Profile

Full Name

Atai Life Sciences N.V.

Ticker Symbol

ATAI

Exchange

NASDAQ

Country

Germany

IPO

June 18, 2021

Indexes

Not included

Employees

54

Key Details

Price

$1.25

Market Cap

$246.89M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$308.00K(-1.91% YoY)

Annual EPS

-$0.93(-272.00% YoY)

PE Ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 19, 25 HC Wainwright & Co.
Buy
Feb 13, 25 HC Wainwright & Co.
Buy
Nov 18, 24 HC Wainwright & Co.
Buy
Nov 18, 24 Canaccord Genuity
Buy

Institutional Ownership

  • What is the ticker symbol for Atai Life Sciences NV?
  • Does Atai Life Sciences NV pay dividends?
  • What sector is Atai Life Sciences NV in?
  • What industry is Atai Life Sciences NV in?
  • What country is Atai Life Sciences NV based in?
  • When did Atai Life Sciences NV go public?
  • Is Atai Life Sciences NV in the S&P 500?
  • Is Atai Life Sciences NV in the NASDAQ 100?
  • Is Atai Life Sciences NV in the Dow Jones?
  • When was Atai Life Sciences NV's last earnings report?
  • When does Atai Life Sciences NV report earnings?
  • Should I buy Atai Life Sciences NV stock now?

What is the ticker symbol for Atai Life Sciences NV?

The ticker symbol for Atai Life Sciences NV is NASDAQ:ATAI

Does Atai Life Sciences NV pay dividends?

No, Atai Life Sciences NV does not pay dividends

What sector is Atai Life Sciences NV in?

Atai Life Sciences NV is in the Healthcare sector

What industry is Atai Life Sciences NV in?

Atai Life Sciences NV is in the Biotechnology industry

What country is Atai Life Sciences NV based in?

Atai Life Sciences NV is headquartered in Germany

When did Atai Life Sciences NV go public?

Atai Life Sciences NV's initial public offering (IPO) was on June 18, 2021

Is Atai Life Sciences NV in the S&P 500?

No, Atai Life Sciences NV is not included in the S&P 500 index

Is Atai Life Sciences NV in the NASDAQ 100?

No, Atai Life Sciences NV is not included in the NASDAQ 100 index

Is Atai Life Sciences NV in the Dow Jones?

No, Atai Life Sciences NV is not included in the Dow Jones index

When was Atai Life Sciences NV's last earnings report?

Atai Life Sciences NV's most recent earnings report was on Nov 13, 2024

When does Atai Life Sciences NV report earnings?

The next expected earnings date for Atai Life Sciences NV is May 15, 2025

Should I buy Atai Life Sciences NV stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page